Colorectal Cancer with Braf V600e Mutation

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-10-20
Clinical Trial Update: Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory [Phase 2]
A Phase 2 clinical trial is evaluating hydroxychloroquine in combination with encorafenib and either cetuximab or panitumumab for metastatic…